ShiraTronics

ShiraTronics is in the early stages of developing a novel and innovative therapy to combat debilitating migraines. ShiraTronics is committed to commercializing new neuromodulation technologies to address this significant unmet clinical need for both patients and physicians. ShiraTronics, the first spin-off from global medical device accelerator NuXcel, is headquartered in both Minneapolis, USA, and Ireland.